Sex: U
Vaccine: DTAPHEPBIP, HIBV, PPV
Symptoms: No adverse event, Product storage error
Clinical narrative: no adverse effects; patient have been administered doses of improperly stored vaccines; This non-valid spontaneous report as received from a nurse and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided.  On unknown dates since 31-DEC-2019, the patients were vaccinated with improperly stored doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # 1621931, expiration date on 26-JAN-2022, measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) rHA, lot# R008690, expiration date on 22-MAR-2020, haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) lot# S023219, expiration date on 03-MAR-2022, measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) rHA, lot# S030093, expiration date on 24-MAR-2021, and varicella virus vaccine live (oka/merck) (VARIVAX) lot# R020673, expiration date on 18-JUL-2020 (dose and route of administration were not provided for all). There was no adverse effect reported.  Administered doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) experienced the temperature excursion above 9 degrees Celsius (15.5C) for 4 hour and 6 minutes.  Administered doses of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) and varicella virus vaccine live (oka/merck) (VARIVAX) experienced the temperature excursion between -14 and -10 degrees Celsius (-11.2C) for 3 hour and 42 minutes. Digital data logger was involved. There were no previous temperature excursions reported. The outcome was provided as "supported".  This report is non-valid due to lack of patients' identifiers.  As of 30-JUL-2020, all telephone attempts to obtain follow-up information have been unsuccessful.  Follow-up information was received by the registered nurse on 12-AUG-2020. This case refers to a patient (gender and age not reported). No information was provided regarding the patient's medical history, concurrent conditions, previous drug reactions, allergies and concomitant medications. It was confirmed that on 12-MAR-2020 at 11:33, the patient was vaccinated with an improperly stored dose of diphtheria toxoid, hepatitis B virus vaccine rHBsAg (yeast), pertussis acellular 3-component vaccine, poliovirus vaccine inactivated (Vero), tetanus toxoid (PEDIARIX) lot # YS4Z5, at a dose of 0.5 mL intramuscularly (IM) on the right thigh (RT), at 11:34 with an improperly stored dose of pneumococcal conjugate vaccine 13, valent lot # AT8585, at a dose of 0.5 mL (IM) on the left thigh (LT) and at 11:35 with an improperly stored dose of haemophilus b conjugate vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot # S023219, at a dose of 0.5 mL IM on the LT. This is one of sixty cases received from the same reporter. This case was previously considered non-valid but per new information received it was determined to be valid.; Sender's Comments:  US-009507513-2003USA002275: